Related Experiment Video

Updated: May 17, 2026

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
08:26

Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages

Published on: February 23, 2024

[A new opportunity in ovarian cancer treatment]

I Sedláková1

  • 1porodnická a Gynekologická klinica LF UK a FN, Hradec Králové, prednosta doc. MUDr. J. Tosner, CSc. Sedlakova@seznam.cz

Ceska Gynekologie
|November 3, 2012
PubMed
Abstract

Insights

Targeted cancer therapy is feasible for ovarian cancer patients, guided by individual tumor traits. Understanding tumor biology aids in identifying patients most likely to benefit from these precise treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Context:

  • Ovarian cancer presents a complex challenge in treatment selection.
  • Personalized medicine approaches are increasingly important in gynecologic oncology.
  • Current treatment strategies require refinement for optimal patient outcomes.

Purpose:

  • To explore the feasibility of targeted treatment strategies in ovarian cancer.
  • To emphasize the role of individual tumor characteristics in treatment selection.
  • To highlight the importance of understanding tumor biology for predicting treatment response.

Summary:

  • This paper discusses targeted treatment options for ovarian cancer patients.
  • Treatment efficacy can be enhanced by considering specific molecular and biological features of individual tumors.
  • A deeper comprehension of tumor biology is crucial for identifying patients who will gain the most benefit from targeted therapies.

Impact:

  • Advances the concept of precision medicine in ovarian cancer care.
  • Provides a foundation for developing more effective, individualized treatment protocols.
  • Suggests a pathway towards improved patient outcomes through biologically informed therapeutic decisions.

More Related Videos

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer07:46

In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer

Published on: August 17, 2010

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...